CHATSWORTH, Calif.--(BUSINESS WIRE)--IRIS INTERNATIONAL, INC. (NASDAQ: IRIS), a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that its IRIS Sample Processing Business Unit has entered into a manufacturing and supply agreement with IDEXX Laboratories, Inc. (NASDAQ: IDXX), for internal centrifugal drive systems and related whole blood separators developed by IRIS for use in the new IDEXX Catalyst Dx™ Chemistry Analyzer for the veterinary market, which IDEXX has begun selling to customers around the world.
